Patent ID: 6204058
Filing Date: 2001-03-20
Classification: A61K,A61M

Abstract:
A process of preparing an autovaccine for administration to an autoimmune disease-suffering mammalian patient to alleviate the patient's autoimmune disease symptoms, which comprises:extracting an aliquot of blood from the patient;modifying the extracted blood aliquot extracorporeally by subjecting it to an immune system-modifying amount of ozone gas and ultraviolet radiation, so as to create in the blood aliquot, in comparison with an equal volume aliquot of said patient's unmodified blood, at least one of the following distinguishing features:(a) increased numbers of leucocytes exhibiting a condensed apoptotic-like morphology;(b) a reduction in the number of leukocytes expressing the MHC Class II leukocyte cell surface specific protein HLA-DR; and(c) an upregulated expression on leukocytes of the cell surface marker CD-11b.